The STEP clinical trial program demonstrated that patients receiving weekly subcutaneous semaglutide achieved average weight loss of 1018% of body weight over 68 weeks, compared to 23% with placebo
105, Honda, Yasushi, et al
Take the First Step Towards Meaningful Weight Loss: Schedule Your Consultation If youre ready to explore how GLP-1 Agonist, as part of a medically supervised program, can help you achieve your weight loss and health goals, contact Allure Medical today
The 30-day guarantee gives time to gather that personal data
Some patients lost up to 25 percent of their body weight
Rapid weight loss increases cholesterol secretion into bile, promoting gallstone formation and triggering complications such as cholecystitis or biliary colic